Login
Companies $RLMD
$3.61 +$0.00 (0.0%) After hours
RELMADA THERAPEUTICS, INC. logo

RELMADA THERAPEUTICS, INC.

relmada.com

What Do They Do?

Develops investigational treatments for bladder cancer and neurological disorders, aimed at patients with those conditions.

How Do They Make Money?

No revenue reported yet.

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Net income
▼ −37% (Loss)
vs −$10.1M in Q3 FY2025

Pipeline refocus Earlier, Relmada focused on esmethadone for depression and other central nervous system disorders. The latest report describes a bladder cancer drug candidate and a neurosteroid for neurological disorders, and says development of esmethadone ended.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support